Spyre Therapeutics, Inc. Earnings Per Share Diluted

Quick Answer

Spyre Therapeutics, Inc. reported Earnings Per Share Diluted of $49.12 (loss) per share for the year ending 2023.

  • Spyre Therapeutics, Inc. showed a decrease of -97.6% in Earnings Per Share Diluted from 2022 to 2023.
  • This data is from Spyre Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 29, 2024.
  • XBRL data for this metric is available from 2020 to 2023 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2020 to 2023), Spyre Therapeutics, Inc.'s Earnings Per Share Diluted has declined by 3,131.6%.
  • Historical annual values: Fiscal year 2023: $49.12 (loss) per share | Fiscal year 2022: $24.86 (loss) per share | Fiscal year 2021: $25.02 (loss) per share | Fiscal year 2020: $1.52 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: